|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 140.34 USD | +2.60% |
|
+0.54% | +43.57% |
| 07-27 | Former FDA chief says Central Mexico may have broad cyclosporiasis contamination | RE |
| 07-23 | How the hunt for value sparked a U.S. private-label revolution | RE |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 16.95x | 3.69x | 9.31x | 0.7x | 8.97x | 14.3x | 3.24% | 63.74B | ||
| 46.22x | 11.99x | 3.54x | 1.36x | 28.6x | 35.19x | 0.56% | 422B | ||
| 15.75x | 3.38x | 2.26x | 0.84x | 8.28x | 11.01x | 3.14% | 47.75B | ||
| 36.27x | 26.96x | 3.85x | 6.79x | 21.21x | 26.41x | 0.25% | 35.9B | ||
| 16.71x | 2.82x | 2.19x | 0.67x | 8.57x | 12.6x | 1.93% | 27.18B | ||
| 23.4x | 3.86x | 0.9x | 1.17x | 12.65x | 16.15x | 0.97% | 16.33B | ||
| 16.86x | -39.68x | 0.15x | 1.59x | 7.73x | 13.49x | 1.47% | 6.48B | ||
| 15.64x | 0.51x | 3.03x | 0.53x | 7.88x | 16.04x | 4.56% | 4.59B | ||
| 14.84x | 1.95x | 0.95x | 1.21x | 8.7x | 10.53x | -.--% | 4.04B | ||
| 10.35x | 2.45x | 0.35x | 0.72x | 5.76x | 9.74x | 4.56% | 2.93B | ||
| 126x | 2.91x | -1.68x | 0.46x | 10.27x | 20.95x | 0.53% | 2.27B | ||
| 18.3x | 3.43x | -0.99x | 0.91x | 9.14x | 13.42x | -.--% | 2.08B | ||
| 15.49x | 2.38x | 1.34x | 0.69x | 6.86x | 8.5x | 2.15% | 1.45B | ||
| 9.94x | - | 3.28x | - | - | - | 2.96% | 54.83M | ||
| Average | 27.34x | 2.05x | 2.03x | 1.36x | 11.12x | 16.03x | 1.88% | 45.49B | |
| Weighted average by Cap. | 37.84x | 9.96x | 3.81x | 1.51x | 22.66x | 28.52x | 1.13% |
- Stock Market
- Stocks
- TGT Stock
- Sector Target Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















